# Test an AI-application that integrates diagnosis codes and text using deep learning-based natural language processing to identify CA patients.

Analytical code for AHA paper evaluating different amyloidsis models (Mayo ATTR-CM score, Echonet-LVH, and Ultromics EchoGo Amyloidosis).


## Main Tables:
- Table 2: Demographics of validation cohort. demographics_tables.ipynb
- Table 3: Performance metrics for validation cohort. performance_metrics.ipynb
- Table 4: Performance metrics for patients with at least moderate LVH. performance_metrics.ipynb
- Table 5: Performance metrics for patients with < 40% LVEF. performance_metrics.ipynb
- Table 6: Fairness metrics for validation cohort. aequitas_tables_figures.ipynb
- Figure 1: NA
- Figure 2: PR and ROC-AUC plots for validation cohort. performance_metrics.ipynb
- Figure 3: Parity metric treemaps. aequitas_tables_figures.ipynb

## Supplemental Tables:
- Figure 1: Absolute group metrics for Mayo ATTR-CM score. aequitas_tables_figures.ipynb
- Figure 2: Absolute group metrics for EchoNet-LVH. aequitas_tables_figures.ipynb
- Figure 3: Absolute group metrics for EchoGo Amyloidosis. aequitas_tables_figures.ipynb
- Table 1: Demographics of EchoNet-LVH predictions. demographics_tables.ipynb
- Table 2: Demographics of EchoGo Amyloidosis predictions. demographics_tables.ipynb
- Table 4: Performance metrics for Pfizer with 50 or more encounters. performance_metrics.ipynb
- Table 5: Performance metrics for EchoGo Amyloidosis and EchoNet-LVH. performance_metrics.ipynb
- Table 6: NA
